Literature DB >> 26249273

[Intra cranial meningiomas and long term use of cyproterone acetate with a conventional dose in women. A report of two cases of tumor decrease after treatment withdrawal].

C Botella1, G Coll2, J-J Lemaire3, B Irthum3.   

Abstract

The action of synthetic progestogens, prescribed at a conventional dose in women, for a meningioma, is still poorly understood, and could be related to progesterone receptors. We report two cases illustrating multiple meningiomas with stabilization or tumor reduction after withdrawal of cyproterone acetate originally prescribed for a long term period. We also review the influence of synthetic progestogens on meningiomas, particularly the impact of treatment withdrawal.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acétate de cyprotérone; Cyproterone acetate; Exogenous sex hormone; Hormone sexuelle exogène; Meningioma; Méningiome; Progestatif de synthèse; Synthetic progestogens

Mesh:

Substances:

Year:  2015        PMID: 26249273     DOI: 10.1016/j.neuchi.2015.05.002

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  6 in total

1.  Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience.

Authors:  Thomas Samoyeau; Marc Zanello; Alexandre Roux; Joseph Benzakoun; Henri Malaize; Sophie Peeters; Gilles Zah-Bi; Myriam Edjlali; Arnault Tauziede-Espariat; Edouard Dezamis; Eduardo Parraga; Fabrice Chrétien; Pascale Varlet; Geneviève Plu-Bureau; Catherine Oppenheim; Johan Pallud
Journal:  J Neurooncol       Date:  2021-01-15       Impact factor: 4.130

2.  Progestin-related WHO grade II meningiomas behavior-a single-institution comparative case series.

Authors:  Antoine Devalckeneer; Rabih Aboukais; Maxime Faisant; Philippe Bourgeois; Vannod-Michel Quentin; Claude-Alain Maurage; Fabienne Escande; Jean-Paul Lejeune
Journal:  Neurosurg Rev       Date:  2021-11-30       Impact factor: 3.042

3.  Meningioma in patients exposed to progestin drugs: results from a real-life screening program.

Authors:  Catherine Oppenheim; Joseph Benzakoun; Thomas Samoyeau; Corentin Provost; Alexandre Roux; Laurence Legrand; Edouard Dezamis; Geneviève Plu-Bureau; Johan Pallud
Journal:  J Neurooncol       Date:  2022-09-06       Impact factor: 4.506

Review 4.  Meningiomas in Gynecology and Reproduction: an Updated Overview for Clinical Practice.

Authors:  Serena Girardelli; Luigi Albano; Giorgia Mangili; Luca Valsecchi; Emanuela Rabaiotti; Paolo Ivo Cavoretto; Pietro Mortini; Massimo Candiani
Journal:  Reprod Sci       Date:  2021-05-10       Impact factor: 2.924

5.  Regression of Giant Olfactory Groove Meningioma and Complete Visual Acuity Recovery after Discontinuation of Cyproterone Acetate.

Authors:  Anne Laure Bernat; Sophie Bonnin; Moujahed Labidi; Nouman Aldahak; Damien Bresson; Schahrazed Bouazza; Sebastien Froelich
Journal:  J Ophthalmic Vis Res       Date:  2018 Jul-Sep

6.  A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas.

Authors:  Keng Siang Lee; John J Y Zhang; Ramez Kirollos; Thomas Santarius; Vincent Diong Weng Nga; Tseng Tsai Yeo
Journal:  Sci Rep       Date:  2022-02-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.